Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jan 20;15(2):229.
doi: 10.3390/diagnostics15020229.

Unlocking the Potential of RNA Sequencing in COVID-19: Toward Accurate Diagnosis and Personalized Medicine

Affiliations
Review

Unlocking the Potential of RNA Sequencing in COVID-19: Toward Accurate Diagnosis and Personalized Medicine

Heba M Saad Eldien et al. Diagnostics (Basel). .

Abstract

COVID-19 has caused widespread morbidity and mortality, with its effects extending to multiple organ systems. Despite known risk factors for severe disease, including advanced age and underlying comorbidities, patient outcomes can vary significantly. This variability complicates efforts to predict disease progression and tailor treatment strategies. While diagnostic and therapeutic approaches are still under debate, RNA sequencing (RNAseq) has emerged as a promising tool to provide deeper insights into the pathophysiology of COVID-19 and guide personalized treatment. A comprehensive literature review was conducted using PubMed, Scopus, Web of Science, and Google Scholar. We employed Medical Subject Headings (MeSH) terms and relevant keywords to identify studies that explored the role of RNAseq in COVID-19 diagnostics, prognostics, and therapeutics. RNAseq has proven instrumental in identifying molecular biomarkers associated with disease severity in patients with COVID-19. It allows for the differentiation between asymptomatic and symptomatic individuals and sheds light on the immune response mechanisms that contribute to disease progression. In critically ill patients, RNAseq has been crucial for identifying key genes that may predict patient outcomes, guiding therapeutic decisions, and assessing the long-term effects of the virus. Additionally, RNAseq has helped in understanding the persistence of viral RNA after recovery, offering new insights into the management of post-acute sequelae, including long COVID. RNA sequencing significantly improves COVID-19 management, particularly for critically ill patients, by enhancing diagnostic accuracy, personalizing treatment, and predicting therapeutic responses. It refines patient stratification, improving outcomes, and holds promise for targeted interventions in both acute and long COVID.

Keywords: COVID-19; RNAseq; gene; host responses; precision medicine; prognosis; transcriptome.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Structure of human coronavirus.

Similar articles

References

    1. WHO . Managing Epidemics: Key Facts About Major Deadly Diseases. World Health Organization; Geneva, Switzerland: 2018.
    1. Cen X., Wang F., Huang X., Jovic D., Dubee F., Yang H., Li Y. Towards precision medicine: Omics approach for COVID-19. Biosaf. Health. 2023;5:78–88. doi: 10.1016/j.bsheal.2023.01.002. - DOI - PMC - PubMed
    1. Abd El-Baky R.M., Shady E.R., Yahia R., Ahmed F.Y., Ramadan M., Ahmed H.R., Al-Kadmy I.M., Ramadan Y.N., Hetta H.F. COVID-19 associated Mucormycosis among ICU patients: Risk factors, control, and challenges. AMB Express. 2023;13:99. doi: 10.1186/s13568-023-01599-8. - DOI - PMC - PubMed
    1. Abdelaal A., Abu-Elfatth A., Bakkar L.M., El-Azeem H.G.A., Hetta H.F., Badawy E.R. Assessment of COVID-19 associated coagulopathy and multiple hemostatic markers: A single center study in Egypt. Infection. 2023;51:655–664. doi: 10.1007/s15010-022-01917-5. - DOI - PMC - PubMed
    1. Abd Ellah N.H., Gad S.F., Muhammad K., E Batiha G., Hetta H.F. Nanomedicine as a promising approach for diagnosis, treatment and prophylaxis against COVID-19. Nanomedicine. 2020;15:2085–2102. doi: 10.2217/nnm-2020-0247. - DOI - PMC - PubMed

LinkOut - more resources